ACE2 and angiotensin 1-7 are increased in a human model of cardiovascular hyporeactivity: Pathophysiological implications

Journal of Nephrology

Volumn 23, Issue 4, 2010, Pages 472-477

  Calò, Lorenzo A ^a   Schiavo, Silvia ^a   Davis, Paul A ^b   Pagnin, Elisa ^a   Mormino, Paolo ^a   D'Angelo, Angela ^a   Pessina, Achille C ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ACE2; Angiotensin 1 7; Arrhythmias; Gitelman's syndrome; Hypertension

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN[1-7]; ANGIOTENSIN I; ANGIOTENSIN I (1-7); DIPEPTIDYL CARBOXYPEPTIDASE; PEPTIDE FRAGMENT;

ARTICLE; BARTTER SYNDROME; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GITELMAN SYNDROME; HEART ARRHYTHMIA; HEART HEMODYNAMICS; HUMAN; MALE; MONONUCLEAR CELL; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BLOOD; HYPERTENSION; PHYSIOLOGY;

ANGIOTENSIN I; BARTTER SYNDROME; FEMALE; GITELMAN SYNDROME; HUMANS; HYPERTENSION; MALE; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A;

EID: 77955440123     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. J Intern Med 2008;264:224-236.
2. Ingelfinger JR. Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease. Curr Opin Nephrol Hypertens 2009;18:79-84.
3. Crackower MA, Sarao R, Oudit GY, et al. Angiotensin converting enzyme 2 is an essential regulator of heart function. Nature 2002;417:822-828.
4. Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, ferrario CM. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension 2004;43:970-976.
5. Oudit GY, Herzenberg AM, Kassiri Z, et al. Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am J Pathol 2006;168:1808-1820.
6. Ferreira AJ, Raizada MK. Are we poised to target ACE2 for the next generation of antihypertensives? J Mol Med 2008;86:685-690.
7. De Mello WC. Opposite effects of angiotensin II and angiotensin (1-7) on impulse propagation, excitability and cardiac arrhythmias. Is the overexpression of ACE2 arrhythmogenic? Regul Pept. 2009;153:7-10.
8. Naesens M, Steels P, Verberckmoes R, Vanrenterghem Y, Kuypers D. Bartter's and Gitelman's Syndromes: from Gene to Clinic. Nephron Physiol 2004;96:65-78.
9. Calò LA. Vascular tone control in humans: the utility of studies in Bartter's/Gitelman's syndromes. Kidney Int 2006;69:963-966.
10. Calò LA, Pessina AC, Semplicini A. Angiotensin II signaling in the Bartter's and Gitelman's syndromes, a negative human model of hypertension. High Blood Press Cardiovasc Prev 2005;12:17-26. (Pubitemid 41032054)
11. Calò LA, Pessina AC. RhoA/Rho-kinase pathway: much more than just a modulation of vascular tone. Evidence from studies in humans. J Hypertens 2007;25:259-264.
12. Calò LA, Puato M, Schiavo S, et al. Absence of vascular remodelling in a high angiotensin-II state (Bartter's and Gitelman's syndromes): implications for angiotensin II signaling pathways. Nephrol Dial Transplant 2008;23:2804-2809.
13. Calo LA, Montisci R, Scognamiglio R, et al. High angiotensin II state without cardiac remodeling (Bartter's and Gitelman's syndromes): are angiotensin II type 2 receptors involved?. 2009;32:832-836.
14. Calò L, Sartore G, Bassi A, et al. Reduced susceptibility of low density lipoprotein to oxidation in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome). J Hypertens 1998;16:1001-1008.
15. Calò LA, Pagnin E, Davis PA, Sartori M, Semplicini A. Oxidative stress related factors in Bartter's and Gitelman's syndromes: relevance for Angiotensin II signaling. Nephrol Dial Transplant 2003;18:1518-1525. (Pubitemid 36939623)
16. Calo LA, Pagnin E, Davis PA, et al. Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's sydrome. A role in the control of vascular tone and implication for hypertension. J Clin Endocrinol Metab 2004; 89:4153-4157.
17. Calò LA, Pagnin E, Ceolotto G, et al. Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter's/Gitelman's syndromes. J Hypertension 2008;26:938-945.
18. Bettinelli A, Tosetto C, Colussi G, Tommasini G, Edefonti A, Bianchetti MG. Electrocardiogram with prolonged QT interval in Gitelman disease. Kidney Int 2002;62:580-584. (Pubitemid 34779771)
19. Cortesi C, Bettinelli A, Emma F, Fischbach M, Bertolani P, Bianchetti MG. Severe syncope and sudden death in children with inborn salt-losing hypokalemic tubulopathies. Nephrol Dial Transplant 2005;20:1981-1983. (Pubitemid 41222618)
20. Scognamiglio R, Negut C, Calò LA. Aborted sudden cardiac death in two patients with Bartter's/Gitelman's syndromes. Clin Nephrol 2007;67:193-197. (Pubitemid 46416381)
21. Scognamiglio R, Calò LA, Negut C, Coccato M, Mormino P, Pessina AC. Myocardial perfusion defects in Bartter and Gitelman syndromes. Eur J Clin Invest 2008;38:888-895.
22. Yagil Y, Yagil C. Hypothesis: ACE2 modulates blood pressure in the mammalian organism. Hypertension 2003;41:871-873.
23. Santos RAS, Ferreira AJ, Pinheiro SV, Sampaio WO, Touyz R, Campagnole-Santos MJ. Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs. Expert Opin Investig Drugs 2005;14:1019-1031. (Pubitemid 41131653)
24. Ferreira AJ, Santos RAS. Cardiovascular actions of angiotensin-(1-7). Braz J Med Biol Res 2005;38:499-507.
25. Ferrario CM. Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation. Hypertension 2006;47:515-521.
26. Tallant EA, Clark MA. Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7). Hypertension 2003;42:574-579.
27. Sampaio WO, Henrique De Castro C, Santos RAS, Schiffrin EL, Touyz RM. Angiotensin-(1-7) counterregulates angiotensin II in human endothelial cells. Hypertension 2007;50:1093-1098.
28. Calo L, Davis PA, Milani M, et al. Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity. Clin Nephrol 1999;51:12-17. (Pubitemid 29027401)
29. Davis PA, Pagnin E, Semplicini A, Avogaro A, Calò LA. Insulin signaling, glucose metabolism and the angiotensin II signaling system. Studies in Bartter's/Gitelman's syndromes. Diabetes Care 2006; 29:469-471.